Home > Insider Trading > Filing (0001127602-15-012337)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
884731	Ariad Pharmaceuticals Inc	ARIA	Biological Products, (No Disgnostic Substances) (2836)	223106987

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1242992	P Timothy Clackson	C/O Ariad Pharmaceuticals Inc 26 Landsdowne Street Cambridge MA 02139	President, R&D, Cso	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-03-19	10,833	$0.00	439,065	No	4	M	Direct
Common Stock	Acquisiton	2015-03-19	20,657	$7.56	460,971	No	4	M	Direct
Common Stock	Disposition	2015-03-19	20,657	$9.00	440,314	No	4	S	Direct
Common Stock	Disposition	2015-03-20	5,417	$8.84	433,648	No	4	S	Direct
Common Stock	Acquisiton	2015-03-23	13,333	$0.00	446,981	No	4	M	Direct
Common Stock	Disposition	2015-03-23	6,667	$8.55	440,314	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2015-03-19	10,833	$0.00	10,833	$0.00
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2015-03-19	20,657	$0.00	20,657	$7.56
Common Stock	Restricted Stock Units	Disposition	2015-03-23	13,333	$0.00	13,333	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,833			No	4	M	Direct
0	2006-10-04	2015-10-04	No	4	M	Direct
0			No	4	M	Direct

Footnotes

Shares were acquired upon vesting of restricted stock units awarded on March 19, 2013.
Shares were acquired upon the exercise of outstanding stock options at $7.56 per share.
Represents shares sold to satisfy withholding tax requirements, pursuant to a Rule 10b5-1 trading plan.
Shares were acquired upon vesting of restricted stock units awarded on March 20, 2012.
Shares were acquired upon the exercise of outstanding stock options at $9.00 per share.
Each restricted stock unit represents a right to receive one share of ARIAD common stock.
Restricted Stock Units vest as to 33-1/3% of the award on each of March 19, 2014, March 19, 2015 and March 19, 2016
Restricted Stock Units vest as to 33-1/3% of the award on March 20, 2013, March 20, 2014 and March 20, 2015.